echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The price of 4 billion large varieties has been reduced by 97%, and foreign companies are actively "on the top"!

    The price of 4 billion large varieties has been reduced by 97%, and foreign companies are actively "on the top"!

    • Last Update: 2021-12-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On December 15, Shandong Province announced the results of the selection of 49 nationally-sourced drug product regulations, with the largest drop of 96.


    The national organization of centralized drug procurement started in 2019, and six batches have been carried out so far.


    Large varieties of injections refresh low prices

    Foreign companies show enthusiasm

    The results of the proposed selection announced by the 49 national drug product regulations of Shandong show that the proposed prices of 36 drugs that are inquired about prices have been stable and have decreased compared with the prices of the original national organization’s centralized procurement to supply Shandong; the prices of 11 drugs proposed to be selected at competitive prices are relatively low.


    Among them, the largest price drop was dexmedetomidine hydrochloride injection (2ml: 0.


    The huge drop in dexmedetomidine hydrochloride injection is also a manifestation of its increasingly fierce market competition to a certain extent


    TOP10 injections by the number of over-rated companies

    (Source: Mi Nei Net)


    Dexmedetomidine injections include dexmedetomidine hydrochloride injection and dexmedetomidine hydrochloride sodium chloride injection


    In addition, the largest price reduction in Shandong’s renewal of the bid was pemetrexed disodium for injection (0.


      

    Four typical models for renewal of bids

    Prices rise or fall, the competition is still excited intense

        

      On November 4, the National Medical Insurance Administration issued the "Notice on Doing a Good Job in Continuing Work after the Expiry of the National Organizational Drug Centralized Procurement Agreement", which pointed out that all national organizations should continue to carry out centralized procurement after the expiration of the drug centralized procurement agreement.


      In the view of Geng Hongwu, general marketing consultant of Jointown Pharmaceutical Group, the renewed bidding of China National Acquisition Corporation is the most representative of Beijing, Shanghai, Guangdong, Hubei and other provinces (cities), forming four typical models, namely, Beijing’s two-way selection inquiry model, Shanghai's comprehensive evaluation bidding model, Guangdong's group bidding model and Hubei's double-envelope bidding model


      Judging from the current actual situation in various places, industry insiders have summarized the following major characteristics of overseas bidding


      Second, the winning price has risen and fallen from the previous round of renewal prices


      Third, the process of renewing the bid is also a process of re-competition of enterprise products, and the market structure is reconstructed


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.